- Home
- VATE vs MAIA Comparison
VATE vs MAIA Comparison
Compare VATE & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- MAIA
- Stock Information
- Founded
- VATE 1994
- MAIA 2018
- Country
- VATE United States
- MAIA United States
- Employees
- VATE N/A
- MAIA N/A
- Industry
- VATE Metal Fabrications
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- MAIA Health Care
- Exchange
- VATE Nasdaq
- MAIA Nasdaq
- Market Cap
- VATE 98.2M
- MAIA 46.7M
- IPO Year
- VATE 1996
- MAIA 2022
- Fundamental
- Price
- VATE $5.33
- MAIA $1.78
- Analyst Decision
- VATE
- MAIA
- Analyst Count
- VATE 0
- MAIA 0
- Target Price
- VATE N/A
- MAIA N/A
- AVG Volume (30 Days)
- VATE 23.8K
- MAIA 425.1K
- Earning Date
- VATE 08-06-2025
- MAIA 08-08-2025
- Dividend Yield
- VATE N/A
- MAIA N/A
- EPS Growth
- VATE N/A
- MAIA N/A
- EPS
- VATE N/A
- MAIA N/A
- Revenue
- VATE $1,066,100,000.00
- MAIA N/A
- Revenue This Year
- VATE N/A
- MAIA N/A
- Revenue Next Year
- VATE N/A
- MAIA N/A
- P/E Ratio
- VATE N/A
- MAIA N/A
- Revenue Growth
- VATE N/A
- MAIA N/A
- 52 Week Low
- VATE $3.25
- MAIA $1.40
- 52 Week High
- VATE $13.79
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- VATE 38.41
- MAIA 50.97
- Support Level
- VATE $5.17
- MAIA $1.60
- Resistance Level
- VATE $5.48
- MAIA $1.95
- Average True Range (ATR)
- VATE 0.22
- MAIA 0.10
- MACD
- VATE -0.00
- MAIA 0.00
- Stochastic Oscillator
- VATE 11.12
- MAIA 54.49
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.